CVS HEALTH (CVS) DIvidends Date & History

Key Takeaways

• CVS Health offers a current dividend yield of approximately 3.4%, paid quarterly at $0.665 per share, annualizing to $2.66.
• The company has demonstrated dividend growth averaging 5-7% annually over the past five years, with increases in four consecutive years prior to recent stability.
• Trailing payout ratio exceeds 190% on GAAP earnings but drops to around 39% on adjusted EPS, indicating potential sustainability concerns short-term but improving forward coverage.
• Operating cash flow of $10.6 billion in 2025 comfortably covers $3.4 billion in dividends paid.
• CVS Health's yield surpasses peers like UNH (2.4%) and HUM (~1%), while rival WBA offers none.
• Latest ex-dividend date was April 23, 2026, with payment on May 4, 2026.

Dividend Overview

CVS Health maintains a consistent quarterly dividend policy, distributing $0.665 per share, which annualizes to $2.66 and provides a yield of about 3.4% as of late April 2026. Payments typically occur in February, May, August, and November, reflecting a reliable schedule for income investors. The company, a major player in pharmacy services and health insurance, positions this dividend as a modest but steady payout rather than a high-yield play. While not classified as a dividend aristocrat, CVS Health exhibits characteristics of a dividend growth stock with historical increases, appealing to those seeking balanced income in the healthcare sector.

Dividend History and Growth

CVS Health has paid dividends consistently since 1991, evolving from smaller payouts to the current $2.66 annual rate. Over the past five years, the dividend has grown at an average annual rate of approximately 5.87% to 7%, with three to four consecutive annual increases recorded recently before stabilizing at $0.665 quarterly in 2026. This reflects a long-term strategy prioritizing shareholder returns amid business expansion in retail pharmacy and Aetna health insurance. No cuts have occurred in recent decades, underscoring payment consistency despite sector pressures.

Dividend Sustainability and Payout Ratio

The trailing twelve-month payout ratio stands high at around 191% based on GAAP earnings per share (EPS) of $1.39 for 2025, raising short-term sustainability flags. However, using adjusted EPS of $6.75, the ratio improves to approximately 39%, aligning with forward estimates of 32-37%. Strong operating cash flow of $10.6 billion in 2025 covers the $3.4 billion in dividends paid, providing solid liquidity support (free cash flow (FCF) was positive at $7.8 billion). Debt levels remain elevated post-Aetna acquisition, but overall financial stability and diversified revenues bolster long-term viability.

Dividend Compared to Industry Peers

In the healthcare and pharmacy retail sector, CVS Health's 3.4% yield outpaces key competitors. UNH offers 2.4%, while HUM yields about 1% and WBA has suspended its dividend entirely. Insurer peers like Cigna (CI) maintain lower ratios with room for growth, but CVS provides superior income relative to its pharmacy-focused profile. This positions CVS favorably for yield comparison among diversified healthcare giants.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It excels at identifying dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to streamline your research.

Is This Stock Attractive for Dividend Investors?

CVS Health may appeal to income-oriented investors comfortable with moderate yield and healthcare sector exposure, particularly those prioritizing cash flow coverage over rapid growth. Its 3.4% payout suits conservative portfolios seeking reliable quarterly income, backed by $10.6 billion in operating cash flow. Dividend growth investors might note the 5-7% historical rate but recent pauses, making it less ideal for aristocrat chasers. Long-term holders could value the diversified model—retail pharmacies, insurance, and services—offering resilience amid economic shifts. However, high trailing payout and debt warrant caution for risk-averse types, as earnings volatility from Medicare Advantage or retail pressures could test sustainability. Balanced investors weighing yield above peers like UNH may find CVS compelling in a diversified strategy.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations